Recently, AXL-GAS6 signal axis has been reported to have a potential key role in NSCLC tumor progression and may be suitable as a prognostic biomarker for identifying high-risk NSCLC brain metastasis patients (34). The gene discussed is GAS6; the disease is non-small cell lung carcinoma.